Zobrazeno 1 - 7
of 7
pro vyhledávání: '"De Cecco, Loris"'
Autor:
Sommariva, Michele1, De Cecco, Loris2, De Cesare, Michelandrea3, Sfondrini, Lucia1, Menard, Sylvie4, Melani, Cecilia5, Delia, Domenico6, Zaffaroni, Nadia3, Pratesi, Graziella3, Uva, Valentina1, Tagliabue, Elda4, Balsari, Andrea1,4 andrea.balsari@unimi.it
Publikováno v:
Cancer Research. Oct2011, Vol. 71 Issue 20, p6382-6390. 9p.
Autor:
Vitali, Caterina1, Bassani, Claudia1, Chiodoni, Claudia1, Fellini, Elisa1, Guarnotta, Carla2, Miotti, Silvia1, Sangaletti, Sabina1, Fuligni, Fabio3, De Cecco, Loris4, Piccaluga, Pier P.3, Colombo, Mario P.1 mariopaolo.colombo@istitutotumori.mi.it, Tripodo, Claudio2
Publikováno v:
Cancer Research. 6/1/2015, Vol. 75 Issue 11, p2387-2399. 13p.
Autor:
Vallacchi, Viviana1, Vergani, Elisabetta1, Camisaschi, Chiara1, Deho, Paola1, Cabras, Antonello D.2, Sensi, Marialuisa3,4, De Cecco, Loris3, Bassani, Niccolò5, Ambrogi, Federico5, Carbone, Antonino2, Crippa, Federica6, Vergani, Barbara7, Frati, Paola1, Arienti, Flavio8, Patuzzo, Roberto6, Villa, Antonello7, Biganzoli, Elia5, Canevari, Silvana3, Santinami, Mario6, Castelli, Chiara1
Publikováno v:
Cancer Research. 1/1/2014, Vol. 74 Issue 1, p130-140. 11p.
Autor:
Cioni B; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ratti S; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Piva A; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tripodi I; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Milani M; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Menichetti F; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Langella T; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Molecular Mechanisms, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via GA Amadeo, Milano, Italy., Chiodoni C; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lecis D; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2023 Jun 01; Vol. 21 (6), pp. 614-627.
Autor:
Petrelli A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Rizzolio S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bellomo SE; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Benelli M; Bioinformatics Unit, Oncology Department, Nuovo Ospedale-Santo Stefano, Prato, Italy., De Cecco L; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Romagnoli D; Bioinformatics Unit, Oncology Department, Nuovo Ospedale-Santo Stefano, Prato, Italy., Berrino E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Torino, Torino, Italy., Orrù C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Ribisi S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Moya-Rull D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Migliore C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Conticelli D; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Maina IM; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Puliga E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Pellegrino B; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy., Llop-Guevara A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Musolino A; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), Parma, Italy., Siena S; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Sartore-Bianchi A; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Antista M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fumagalli U; Digestive Surgery, European Institute of Oncology, IRCCS, Milan, Italy., De Manzoni G; Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Section of Surgery, University of Verona, Verona, Italy., Degiuli M; Department of Oncology, University of Torino, Orbassano, Italy., Baiocchi GL; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy., Amisano MF; Department of Surgery, Santo Spirito Hospital, ASL-AL, Rome, Italy., Ferrero A; General and Oncological Surgery, Mauriziano Hospital, Torino, Italy., Marchiò C; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Medical Sciences, University of Torino, Torino, Italy., Corso S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Giordano S; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy.
Publikováno v:
Cancer research [Cancer Res] 2023 May 15; Vol. 83 (10), pp. 1699-1710.
Autor:
Di Modica M; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gargari G; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Regondi V; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bonizzi A; Department of Biomedical and Clinical Sciences 'L. Sacco,' Università degli Studi di Milano, Milan, Italy., Arioli S; Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi di Milano, Milan, Italy., Belmonte B; Tumor Immunology Unit, Department PROMISE, Università degli Studi di Palermo, Palermo, Italy., De Cecco L; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fasano E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchi F; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bertolotti A; Department of Pathology, Fondazione IRCSS Istituto Nazionale Tumori, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department PROMISE, Università degli Studi di Palermo, Palermo, Italy.; IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy., Villani L; Pathology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Corsi F; Department of Biomedical and Clinical Sciences 'L. Sacco,' Università degli Studi di Milano, Milan, Italy.; Breast Unit, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Guglielmetti S; Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi di Milano, Milan, Italy., Balsari A; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Department of Biomedical Science for Health, Università degli Studi di Milano, Milan, Italy., Triulzi T; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. elda.tagliabue@istitutotumori.mi.it.
Publikováno v:
Cancer research [Cancer Res] 2021 Apr 15; Vol. 81 (8), pp. 2195-2206. Date of Electronic Publication: 2021 Jan 22.
Autor:
Majorini MT; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Rigoni A; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Triulzi T; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fontanella E; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Jachetti E; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. daniele.lecis@istitutotumori.mi.it mariopaolo.colombo@istitutotumori.mi.it., Lecis D; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. daniele.lecis@istitutotumori.mi.it mariopaolo.colombo@istitutotumori.mi.it.
Publikováno v:
Cancer research [Cancer Res] 2020 Jun 01; Vol. 80 (11), pp. 2311-2324. Date of Electronic Publication: 2020 Mar 16.